Bio-Rad Laboratories, Inc. Stock NYSE
Stocks
BIO.B
US0905721082
Medical Equipment, Supplies & Distribution
|
Delayed
NYSE
04:10:00 2026-08-20 pm EDT
|
5-day change | 1st Jan Change | ||
| 365.08 USD | +8.33% |
|
-.--% | +17.50% |
| Market Cap | 10.03B 8.83B 8.35B 7.57B 14.22B 963B 14.3B 99.93B 38.59B 492B 37.68B 36.86B 1,580B | P/E 2026 * |
45.4x | P/E 2027 * | 44.4x |
|---|---|---|---|---|---|
| Enterprise Value | 9.29B 8.17B 7.72B 7B 13.16B 891B 13.23B 92.47B 35.71B 455B 34.86B 34.11B 1,462B | EV / Sales 2026 * |
3.61x | EV / Sales 2027 * | 3.45x |
| Free-Float |
60.17% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| BIO.B | Delayed | |
Deutsche Boerse AG
| BUW | Delayed |
Last Transcript: Bio-Rad Laboratories, Inc.
| 1 day | +8.33% | ||
| 3 months | +23.13% | ||
| 6 months | +35.94% | ||
| Current year | +17.50% |
| Current year | 244.54 |  | 365.08 |
| 1 year | 244.54 | | 365.08 |
| 3 years | 0 | | 365.08 |
| 5 years | 0 | | 784.4 |
| 10 years | 0 | | 818.6 |
| Manager | Title | Age | Since |
|---|---|---|---|
Norman Schwartz
CEO | Chief Executive Officer | 76 | 2002-12-31 |
| President | 61 | 2024-09-08 | |
Roop Lakkaraju
DFI | Director of Finance/CFO | 55 | 2024-04-14 |
| Director | Title | Age | Since |
|---|---|---|---|
Norman Schwartz
CHM | Chairman | 76 | 2011-12-31 |
Jeffrey Edwards
BRD | Director/Board Member | 73 | 2017-04-24 |
Gregory Hinckley
BRD | Director/Board Member | 79 | 2017-04-24 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +8.33% | -.--% | - | - | 10.03B | |
| -0.98% | -3.61% | -24.91% | +3.20% | 175B | |
| -2.26% | -3.70% | -6.98% | +11.55% | 114B | |
| -0.03% | -3.43% | -1.43% | +68.73% | 57.98B | |
| -1.68% | -1.07% | -1.61% | -29.97% | 50.07B | |
| -1.00% | +2.74% | +13.85% | +53.00% | 50.13B | |
| -0.96% | -3.97% | +29.36% | -7.85% | 32.71B | |
| -0.46% | +1.66% | - | - | 30.77B | |
| -0.36% | +1.06% | +44.06% | -0.05% | 26.44B | |
| +0.28% | +5.23% | +26.98% | -3.89% | 23.96B | |
| Average | +0.05% | +1.59% | +9.92% | +11.84% | 62.36B | |
| Weighted average by Cap. | -0.97% | -0.18% | -3.49% | +12.57% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 2.57B 2.26B 2.14B 1.94B 3.64B 247B 3.66B 25.58B 9.88B 126B 9.65B 9.44B 404B | 2.63B 2.32B 2.19B 1.99B 3.73B 253B 3.75B 26.21B 10.12B 129B 9.88B 9.67B 414B |
| Net income | 225M 198M 187M 170M 319M 21.58B 320M 2.24B 865M 11.01B 844M 826M 35.39B | 230M 202M 191M 173M 325M 22.05B 327M 2.29B 883M 11.25B 862M 844M 36.16B |
| Net Debt | -749M -659M -623M -565M -1.06B -71.9B -1.07B -7.46B -2.88B -36.69B -2.81B -2.75B -118B | -965M -849M -803M -728M -1.37B -92.67B -1.38B -9.61B -3.71B -47.29B -3.62B -3.55B -152B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-28 | $0.000000 | - | 9 |
| 26-09-25 | $0.000000 | - | 8 |
| 26-09-24 | $0.000000 | - | 9 |
| 26-09-23 | $0.000000 | - | 108 |
| 26-09-22 | $0.000000 | - | 10 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- BIO Stock
- BIO.B Stock
Select your edition
All financial news and data tailored to specific country editions
